MarketCapTrends
ALKS

Alkermes plc (ALKS)

NASDAQ · Healthcare

Alkermes plc annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Alkermes plc shareholder equity for the quarter ending December 31, 2025 were 1.82B, a 24.19% increase year-over-year.
  • Alkermes plc shareholder equity for 2025 were 1.82B, a 24.19% increase from 2024.
  • Alkermes plc shareholder equity for 2024 were 1.46B, a 21.81% increase from 2023.
  • Alkermes plc shareholder equity for 2023 were 1.20B, a 15.23% increase from 2022.
  • Alkermes plc shareholder equity for 2022 were 1.04B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Alkermes plc Annual Shareholder Equity (Millions of US $)
2025$1,819
2024$1,465
2023$1,203
2022$1,044
2021$1,113
2020$1,067
2019$1,085
2018$1,171
2017$1,203
2016$1,209
2015$1,314
2014$1,397
2013$1,065
2012$854
2011$392
Alkermes plc Quarterly Shareholder Equity (Millions of US $)
2025-12-31$1,819
2024-12-31$1,465
2023-12-31$1,203
2022-12-31$1,044
2021-12-31$1,113
2020-12-31$1,067
2019-12-31$1,085
2018-12-31$1,171
2017-12-31$1,203
2016-12-31$1,209
2015-12-31$1,314
2014-12-31$1,397
2013-12-31$1,065
2013-03-31$952
2012-03-31$854
2011-03-31$392

Alkermes plc Shareholder Equity — FAQ

Alkermes plc (ALKS) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ALKS's shareholder equity history?

The chart and table above show Alkermes plc's shareholder equity by year and by quarter, including the growth rate.